1747|10000|Public
50|$|Patent {{publications}} {{are each}} assigned {{at least one}} classification term indicating the subject to which <b>the</b> <b>invention</b> <b>relates</b> and may also be assigned further classification and indexing terms to give further details of the contents.|$|E
50|$|The Lambert {{friction}} gearing disk drive transmission {{was invented by}} John William Lambert originally in 1904. <b>The</b> <b>invention</b> <b>relates</b> to a friction disk drive transmission for automobiles that is gearless. He saw {{the need for a}} simple transmission of engine power to an automobile's drive wheels.|$|E
50|$|Patent {{publications}} {{from all}} of the Contracting States (and also most others) are each assigned at least one classification symbol indicating the subject to which <b>the</b> <b>invention</b> <b>relates</b> and may also be assigned further classification symbols and indexing codes to give further details of the contents.|$|E
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to a {{polymer mixture}} {{comprising}} polylactic acid. <b>The</b> <b>invention</b> furthermore <b>relates</b> to {{a method for}} producing an extruded product and the extruded product obtained therewith. <b>The</b> present <b>invention</b> furthermore <b>relates</b> to methods for producing a starting material for a foamed moulded product and the starting material obtained therewith. <b>The</b> present <b>invention</b> moreover <b>relates</b> to methods for producing a foamed moulded product and the moulded product obtained therewith. <b>The</b> present <b>invention</b> also <b>relates</b> to applications of these product...|$|R
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to {{a crystal}}. In {{particular}} <b>the</b> present <b>invention</b> <b>relates</b> to a crystal of the N-domain of ACE protein. <b>The</b> present <b>invention</b> also <b>relates</b> to methods, processes, domain, specific modulators, pharmaceutical compositions and {{uses of the}} N-domain crystal and the structure co-ordinates thereof...|$|R
40|$|<b>The</b> present <b>invention</b> <b>related</b> to <b>the</b> {{field of}} {{three-dimensional}} scanning. In particular, <b>the</b> present <b>invention</b> <b>relates</b> {{to a system}} and a method for the advanced scanning of surfaces and for the simulation of the dynamic deformation of surfaces. Still more in particular, <b>the</b> present <b>invention</b> <b>relates</b> t a system and a method particularly appropriate for scanning and simulating the deformation of anatomical surfaces...|$|R
5000|$|First, discoveries, {{scientific}} theories, mathematical methods, aesthetic creations, schemes, {{rules and}} methods for performing mental acts, playing games or doing business, programs for computers and presentations of information are not regarded as inventions and {{are excluded from}} patentability {{only to the extent}} that <b>the</b> <b>invention</b> <b>relates</b> to those areas as such. This is [...] "a negative, non-exhaustive list of what should not be regarded as an invention within the meaning of Article 52(1) EPC." [...] (For further information, see also: Software patents under the EPC).|$|E
50|$|In 2013, Milford Graves {{along with}} Drs.Carlo Tremolada and Carlo Ventura {{received}} a patent for an invention {{that relates to}} a process of preparing a non-expanded tissue derivative, that is not subjected to cell proliferation in vitro, which has a vascular-stromal fraction enriched in stem and multipotent elements, such as pericytes and/or mesenchymal stem cells, or for preparing non-embryonic stem cells obtained from a tissue sample or from such tissue derivative, wherein the tissue derivative or such cells are subjected to vibrations derived from a heart sound to control the degree of differentiation or possible differentiation of the stem and multipotent elements into several other types of cells and optimize their potency. <b>The</b> <b>invention</b> <b>relates</b> also to a device for carrying out the process, to stem cells obtainable by the process {{as well as a}} drug for the regeneration of an animal tissue.|$|E
40|$|<b>The</b> <b>invention</b> <b>relates</b> to {{the field}} of {{characterization}} of physical properties of a target volume by using electromagnetic waves. More precisely, <b>the</b> <b>invention</b> <b>relates,</b> according to a first aspect, to a method for determining values of physical parameters of a target volume. According to a second aspect, <b>the</b> <b>invention</b> <b>relates</b> to a device for determining sail value...|$|E
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to yeast strains and, in particular, to yeast stains {{for use in}} {{fermentation}} processes. <b>The</b> <b>invention</b> also <b>relates</b> to {{methods of}} fermentation using the yeast strains of <b>the</b> <b>invention</b> either alone or {{in combination with other}} yeast strains. <b>The</b> <b>invention</b> thither <b>relates</b> to methods for the selection of yeast strains suitable for fermentation cultures by screening for various metabolic products and the use of specific nutrient sources...|$|R
40|$|<b>The</b> present <b>invention</b> <b>relates</b> {{generally}} to vaccine strains of Brachyspira hyodysenteriae. In particular, <b>the</b> present <b>invention</b> <b>relates</b> to isolated live vaccine strains of B. hyodysenteriae lacking {{one or more}} virulence factors. <b>The</b> present <b>invention</b> also <b>relates</b> to methods of identifying and preparing vaccine strains, as well as vaccine compositions against diarrhoeal diseases and methods and kits for diagnosing same...|$|R
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to <b>the</b> medical field. In a first aspect <b>the</b> present <b>invention</b> <b>relates</b> to novel {{water soluble}} cyclodextrin-curcumin {{complexes}} having a pharmacological activity, in particular an anti-tumour and/or anti-inflammatory activity, and improved physico-chemical properties. In a second aspect, <b>the</b> present <b>invention</b> <b>relates</b> to {{a method for}} preparation of said water soluble curcumin derivatives. <b>The</b> <b>invention</b> further <b>relates</b> in a third aspect to a pharmaceutical composition comprising an effective amount of said water soluble curcumin derivatives. In a fourth aspect, <b>the</b> present <b>invention</b> concerns <b>the</b> use of said water soluble cucumin derivatives as a medicament {{and the use of}} said water soluble curcumin derivatives for the preparation of a medicament for the treatment of cancer and inflammatory diseases. In a fifth aspect, <b>the</b> present <b>invention</b> <b>relates</b> to <b>the</b> use of a pharmaceutical composition comprising said water soluble curcumin derivatives in the treatment of cancer and inflammatory diseases and to a new pharmaceutical composition comprising said water soluble curcumin derivatives...|$|R
40|$|<b>The</b> <b>invention</b> <b>relates</b> to a {{semiconductor}} component {{having a}} multi-layer structure, wherein a bypass diode is monolithically {{integrated into the}} semiconductor component. The invention further relates to modules that are constructed from several of said semiconductor components. <b>The</b> <b>invention</b> <b>relates</b> in particular to multi-junction solar cells in photovoltaics...|$|E
40|$|The present {{invention}} {{refers to}} synthetic Bovine Respiratory Syncytium virus genes. Also <b>the</b> <b>invention</b> <b>relates</b> to live attenuated Bovine Herpesvirus recombinants carrying such synthetic genes. Furthermore, <b>the</b> <b>invention</b> <b>relates</b> to vaccines {{based on these}} live attenuated recombinants, {{for the protection of}} cattle against both Bovine herpesvirus infection and against Bovine Respiratory Syncytium virus infection. Also <b>the</b> <b>invention</b> <b>relates</b> to methods for the preparation of such live attenuated recombinants and to methods for the preparation of such vaccines. Furthermore, <b>the</b> <b>invention</b> <b>relates</b> to live Bovine herpesvirus recombinant particles carrying a class II membrane glycoprotein and to live Bovine herpesvirus recombinants carrying a heterologous gene fused to a class II membrane glycoprotein membrane anchor, to vaccines based thereon, and to methods for the preparation of such recombinants, such particles and such vaccines...|$|E
40|$|<b>The</b> <b>invention</b> <b>relates</b> to a {{hydrogen}} storage material comprising an alloy of magnesium. The invention further relates to an {{electrochemically active material}} and an electrochemical cell provided {{with at least one}} electrode comprising such {{a hydrogen}} storage material. Also, <b>the</b> <b>invention</b> <b>relates</b> to electronic equipment comprising such an electrochemical cell...|$|E
40|$|<b>The</b> present <b>invention</b> <b>relates</b> {{generally}} to cinnamate crosslinkers. Specifically, <b>the</b> present <b>invention</b> <b>relates</b> to gels, biochips, and functionalized surfaces useful as probes, in assays, in gels, and for drug delivery, {{and methods of}} making the same using a newly-discovered crosslinking configuration...|$|R
40|$|<b>The</b> present <b>invention</b> <b>relates</b> toa {{method for}} {{determination}} of the state-of- charge (SoC) of a rechargeable battery {{as a function of}} the Electro-Motive Force (EMF) prevailing in said battery. <b>The</b> <b>invention</b> also <b>relates</b> to a method for measuring the relation between the state-of-charge (SoC) and <b>the</b> EMF. <b>The</b> <b>invention</b> further <b>relates</b> to an apparatus for {{determination of the}} State-of-Charge (SoC) of a rechargeable battery {{as a function of the}} Electro-Motive Force (EMF) prevailing in said battery...|$|R
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to {{a method}} for {{screening}} for a bacterium exhibiting enhanced survival properties in the gastro-intestinal tract. <b>The</b> present <b>invention</b> further <b>relates</b> to {{a method for}} screening for culture conditions that provide a bacterium exhibiting enhanced survival properties in the gastro-intestinal tract. <b>The</b> present <b>invention</b> further <b>relates</b> to a method for modulating the expression of certain polynucleotides. <b>The</b> present <b>invention</b> further <b>relates</b> to a method for the preparation of a bacterium exhibiting enhanced survival properties in the gastro-intestinal tract. <b>The</b> present <b>invention</b> further <b>relates</b> to a bacterium exhibiting enhanced survival properties in the gastro-intestinal tract. <b>The</b> present <b>invention</b> further <b>relates</b> to a method for the preparation of a food composition. <b>The</b> present <b>invention</b> further <b>relates</b> to a food composition. <b>The</b> present <b>invention</b> further <b>relates</b> to <b>the</b> use of certain polynucleotides in the screening for a bacterium exhibiting enhanced survival properties in the gastro- intestinal tract and/or the screening for culture conditions that provide a bacterium exhibiting enhanced survival properties in the gastro-intestinal tract and/or for the control of culture conditions providing a bacterium exhibiting enhanced survival properties in the gastro-intestinal tract. <b>The</b> present <b>invention</b> further <b>relates</b> to a method for controlling culture conditions providing a bacterium exhibiting enhanced survival properties in the gastro-intestinal tract...|$|R
40|$|<b>The</b> <b>invention</b> <b>relates</b> to {{isolated}} microorganisms {{useful for}} the biodegradation of polycylic aromatic hydrocarbons (PAHs). Specifically, <b>the</b> <b>invention</b> <b>relates</b> to isolated Stenotrophomonas maltophilia VUN 10, 010, Pseudomonas fluorescens VUN 10, 011, Burkholderia sp. VUN 10, 013 and Penicillium janthinellum. The invention further relates to a bacterial consortium having the ability to degrade PAHs...|$|E
40|$|<b>The</b> <b>invention</b> <b>relates</b> {{generally}} to virus resistant plants, wherein {{the plants are}} resistant to aphid transmitted viruses. In particular, <b>the</b> <b>invention</b> <b>relates</b> to a method for protecting a plant from aphid-borne viral infection, comprising the step of introducing a nucleic acid molecule into a plant, which nucleic acid molecule codes for an aphid transmission factor...|$|E
40|$|<b>The</b> <b>invention</b> <b>relates</b> to {{a sensor}} array for {{detecting}} {{the presence of}} a target, and in particular to a sensor array where a target is detected based on a detection of a surface plasmon resonance (SPR). Moreover, <b>the</b> <b>invention</b> <b>relates</b> to an optical detection system comprising a sensor array, and to a method for detecting {{the presence of a}} target on a sensor array...|$|E
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to {{a process}} for the {{preparation}} of Telmisartan by hydroxycarbonylation of compound of formula (V), wherein X is a substituent which can {{be transformed into a}} carboxy group by hydroxycarbonylation. <b>The</b> <b>invention</b> also <b>relates</b> to intermediates for the synthesis of Telmisartan...|$|R
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to {{a method}} for {{reinforcing}} mineral-based materials using reinforced fiber material. More particularly, <b>the</b> present <b>invention</b> <b>relates</b> {{a method for}} more uniformly dispensing a fiber material with a mineral-based material, such as cement paste. Institute Of Paper Science And Technology, Inc...|$|R
40|$|<b>The</b> <b>invention</b> {{disclosed}} herein <b>relates</b> to thermoelectrically-active p-type Zintl phase {{materials as}} well as devices utilizing such compounds. Such thermoelectric materials and devices {{may be used to}} convert thermal energy into electrical energy, or use electrical energy to produce heat or refrigeration. Embodiments of <b>the</b> <b>invention</b> <b>relate</b> to p-type thermoelectric materials related to the compound Yb. sub. 14 MnSb. sub. 11...|$|R
40|$|<b>The</b> <b>invention</b> <b>relates</b> to glass {{ceramics}} {{on the basis}} of the lithium disilicate system, which can be easily mechanically machined in an intermediate stage of the crystallization and which represent high-strength, highly translucent and chemically stable {{glass ceramics}} after complete crystallization. Furthermore, <b>the</b> <b>invention</b> <b>relates</b> to a method for producing said glass ceramics. The glass ceramics according to the invention are used as dental material...|$|E
40|$|<b>The</b> <b>invention</b> <b>relates</b> {{generally}} to {{a method for}} the high expression of immunoglobulin in plants. In particular, <b>the</b> <b>invention</b> <b>relates</b> to a plant expression vector comprising an expression cassette comprising a first polynucleotide sequence coding for an immunoglobulin molecule, a promoter capable of promoting expression of said first polynucleotide sequence and a second polynucleotide sequence coding for a terminator, wherein said promoter and second polynucleotide sequence are both of plant origin...|$|E
40|$|<b>The</b> <b>invention</b> <b>relates</b> to {{a method}} and {{apparatus}} for {{the measurement of}} electrical conductivity {{and in particular the}} measurement thereof in materials having low electrical conductivity. In particular, although not exclusively, <b>the</b> <b>invention</b> <b>relates</b> to an apparatus and method for measuring electrical 10 conductivity in low conductivity bulk materials. However, the method and apparatus of the present invention may also be employed with materials having high electrical conductivity. ...|$|E
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to polymer {{composite}} materials containing carbon nanotubes, particularly to those containing singled-walled nanotubes. <b>The</b> <b>invention</b> provides a polymer composite comprising {{one or more}} base polymers, one or more functionalized m-phenylenevinylene- 2, 5 -disubstituted-p-phenylenevinylene polymers and carbon nanotubes. <b>The</b> <b>invention</b> also <b>relates</b> to functionalized m-phenylenevinylene- 2, 5 -disubstituted-p-phenylenevinylene polymers, particularly to m-phenylenevinylene- 2, 5 -disubstituted-p-phenylenevinylene polymers having side chain functionalization, and more particularly to m-phenylenevinylene- 2, 5 -disubstituted-p-phenylenevinylene polymers having olefin side chains and alkyl epoxy side chains. <b>The</b> <b>invention</b> further <b>relates</b> to methods of making polymer composites comprising carbon nanotubes...|$|R
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to novel {{methods for}} the design of proteins, in particular, cytokines. These methods allow the {{stabilisation}} of such cytokines, as well as modification of their selectivity/specificity for their cognate receptors. <b>The</b> <b>invention</b> also <b>relates</b> to various modified proteins that have been designed by the methods of <b>the</b> <b>invention...</b>|$|R
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to {{methods and}} {{pharmaceutical}} compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, <b>the</b> present <b>invention</b> <b>relates</b> to a ligand of the sonic hedgehog signaling pathway {{for use in}} the cardioprotection of a subject who experienced a myocardial infarction...|$|R
40|$|<b>The</b> <b>invention</b> <b>relates</b> to {{the field}} of biochemistry, {{molecular}} biology and food production. More in particular, <b>the</b> <b>invention</b> <b>relates</b> to methods and means for regulating gene expression. Even more in particular, <b>the</b> <b>invention</b> <b>relates</b> to CodY target sequences. Herein we show that CodY represses its target genes by binding to specific DNA sequences upstream of the respective genes. A conserved target site was identified by analyzing upstream sequences of derepressed genes in a delta codY L. lactis MG 1363 derivative, as identified in a DNA micro-array study. The present application furthermore discloses CodY target sequences from other gram-positive bacteria, like B. subtilis and Streptococcus. Hence, the invention provides CodY target sequences that may be used in different applications to repress or derepress gene expression...|$|E
40|$|<b>The</b> <b>invention</b> <b>relates</b> to a cobalt {{compound}} of the formula Formula 1, {{a process for}} its production and its application as a substance-specific carrier substance of oxygen (oxygen carrier) for the separation of oxygen from oxygen-containing compounds. <b>The</b> <b>invention</b> <b>relates</b> to a cobalt {{compound of}} the formula Formula 1, a process for its production and its application as a substance-specific carrier substance of oxygen (oxygen carrier) for the separation of oxygen from oxygen-containing compounds...|$|E
40|$|<b>The</b> <b>invention</b> <b>relates</b> to {{a method}} for the {{manufacture}} of a thin-layer battery stack on a three-dimensional substrate. The invention further relates to a thin-layer battery stack on a three-dimensional substrate obtainable by such a method. Moreover, <b>the</b> <b>invention</b> <b>relates</b> to a device comprising such a battery stack. The method according to the invention provides a rapid way to manufacture battery stacks on three-dimensional substrate, and the obtained products are of superior quality...|$|E
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to sub-millimeter wave {{frequency}} heterodyne imaging systems. More specifically, <b>the</b> present <b>invention</b> <b>relates</b> to a sub-millimeter wave frequency {{heterodyne detector}} system for imaging {{the magnitude and}} phase of transmitted power through or reflected power off of mechanically scanned samples at sub-millimeter wave frequencies...|$|R
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to a {{three-dimensional}} cell culture system for culturing adipocytes. <b>The</b> <b>invention</b> also <b>relates</b> to methods for culturing adipocytes and for obtaining adipocytes from preadipocytes in cell culture. Aspects of <b>the</b> <b>invention</b> further <b>relate</b> to methods for evaluating interactions between adipocytes and other cell types, and for evaluating responses of adipocytes to environmental stimuli. This enables {{a greater understanding}} of the mechanisms involved in cell and tissue interactions and has implications in the fields of obesity, diabetes, inflammation and related diseases...|$|R
40|$|<b>The</b> present <b>invention</b> <b>relates</b> to a {{compound}} represented by formula (E). <b>The</b> present <b>invention</b> also <b>relates</b> to {{a compound}} {{represented by the}} formula (E) {{for use in the}} treatment or prevention of diseases linked to protein aggregation and/or neurodegenerative diseases. Moreover, <b>the</b> present <b>invention</b> <b>relates</b> to pharmaceutical and diagnostic compositions comprising the compound of <b>the</b> <b>invention</b> as well as to a kit. Furthermore, <b>the</b> present <b>invention</b> <b>relates</b> to a method of imaging deposits of aggregated protein. A kit for preparing a detectably labelled compound of <b>the</b> present <b>invention</b> is also disclosed. Formula (E) wherein X, Y and L are independently nondirectionally selected from -C(R 1) (R 2) -, -C(R 3) =, -N(R 4) -, -N=, -N+(R 5) =, -O- and -S-; M and Z are independently nondirectionally selected from formula (I) and formula (II) ...|$|R
